BACK TO FAESFARMA.COM
Other Relevant Information
Type
Statement 10/31/2024. January- September 2024 results. Download
Statement 07/30/2024. Business report first half 2024. Download
Statement 06/25/2024. Relevant aspects of the Shareholders' Meeting. Download
Statement 06/25/2024. Change of presidency of the Audit and Compliance Committee. Download
Statement 06/25/2024. Payment of complementary dividend for 2023. Download
Statement 05/02/2024. Proposal for the appointment of a CEO. Download
Statement 04/26/2024. January-March 2024 results. Download
Type
Statement 11/30/2023. Interim dividend 2023. Download
Statement 10/25/2023. January- September 2023 results. Download
Statement 06/27/2023. News about bilastine. Download
Statement 05/04/2023. Acquisition Novosci. Download
Statement 04/26/2023. January-March 2023 results. Download
Statement 03/29/2023. Capital Markets Day presentation. Download
Statement 03/27/2023. Approval of the scrip dividend. Download
Statement 02/28/2023. Business update information 2022. Download
Type
Statement 12/22/2022. Appointments of Commissions. Download
Statement 10/27/2022. January- September 2022 results. Download
Statement 07/28/2022. January-June 2022 results. Download
Statement 04/29/2022. January-March 2022 results. Download
Statement 03/22/2022. Capital Market presentation. Download
Statement 02/25/2022. January-December results. Download
Type
Statement 10/29/2021. Financial results and business update third quarter 2021. Download
Statement 04/12/2021. Capital market presentation. Download
Statement 02/26/2021. Business update information 2020. Download
Statement 01/15/2021. Faes Farma expands its industrial capacity. Download